Patents-Review.com
ClassID:

170500 ⎘

G01N2333/70585 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants CD44

Recent Application in this class:
#1
20260124250
2026-05-07

METHODS FOR SELECTING CULTURED CORNEAL ENDOTHELIAL CELLS

 #2
20260049988
2026-02-19

METHOD OF BREAST CANCER BIOMARKER DETECTION USING A BIOSENSOR BASED ON A FIBER-OPTIC BALL RESONATOR

 #3
20260008845
2026-01-08

BIOMARKERS FOR FIBROSIS TREATMENT USING ANTI-CLAUDIN-1 ANTIBODIES

 #4
20250377360
2025-12-11

METHODS FOR DETECTING A CANCER

 #5
20250340662
2025-11-06

BINDING PROTEIN

 #6
20250123282
2025-04-17

METHODS FOR EVALUATION AND TREATMENT OF TYROSINE KINASE INHIBITOR (TKI)-RESISTANT ACUTE MYELOID LEUKEMIA

 #7
20250052770
2025-02-13

GLX-DERIVED MOLECULE DETECTION

 #8
20240201168
2024-06-20

COMPOSITION FOR DIAGNOSIS OR TREATMENT OF ANTICANCER DRUG RESISTANCE

 #9
20230067928
2023-03-02

METHODS FOR PROGNOSING AND PREVENTING METASTATIC LIVER DISEASE

 #10
20230058124
2023-02-23

PREECLAMPSIA BIOMARKERS AND USE THEREOF

 #11
20220381782
2022-12-01

Method of isolating and detecting exosomal biomarkers of glioblastoma malignancy

 #12
20220252602
2022-08-11

ARTIFICIAL INTELLIGENCE FOR EARLY CANCER DETECTION

 #13
20220137041
2022-05-05

DEVICE FOR METHODS OF DETECTING CANCER

 #14
20220099670
2022-03-31

METHOD FOR DETECTING CELLS

 #15
20220050117
2022-02-17

GLX-DERIVED MOLECULE DETECTION

 #16
20210301351
2021-09-30

Biomarker composition for predicting cancer malignant prognosis induced by microplastic exposure

 #17
20210062277
2021-03-04

BIOMARKERS FOR RADIATION TREATMENT

 #18
20200256873
2020-08-13

Methods for treating, preventing and predicting risk of developing breast cancer

 #19
20200200758
2020-06-25

CANCER MARKERS AND METHODS OF USE THEREOF

 #20
20200155680
2020-05-21

IMMUNE MODULATORS IN COMBINATION WITH RADIATION TREATMENT

 #21
20200002401
2020-01-02

CD44 BINDING PEPTIDES

 #22
20190346445
2019-11-14

Biomarkers for lung cancer stem cells

 #23
20190302120
2019-10-03

Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas

 #24
20190144931
2019-05-16

System and method for capturing and analyzing cells

 #25
20190079093
2019-03-14

COMPOSITIONS AND METHODS FOR IDENTIFYING A RISK OF CANCER IN A SUBJECT

 #26
20190077852
2019-03-14

ANTI-EMP2 THERAPY REDUCES CANCER STEM CELLS

 #27
20190064164
2019-02-28

Markers capable of distinguishing cell pluripotency and uses thereof

 #28
20180334706
2018-11-22

System and method for capturing and analyzing cells

 #29
20180305769
2018-10-25

Biomarkers for radiation treatment

 #30
20180296706
2018-10-18

Micro- and nano-device for cartilage injury detection and treatment

 #31
20180296524
2018-10-18

Methods for detection and eradication of myeloid leukemia stem cells

 #32
20180252716
2018-09-06

Device for early detection of disease states

 #33
20180231558
2018-08-16

Methods for prognosing and preventing metastatic liver disease

 #34
20180171015
2018-06-21

Method of Increasing GIPCR Signalization in the Cells of a Scoliotic Subject

 #35
20180120320
2018-05-03

NOVEL METHOD FOR ANALYZING CIRCULATING TUMOR CELLS OF A PATIENT FOR THE PRESENCE OF METASTASIS-INITIATING CELLS

 #36
20170360932
2017-12-21

IMMUNE MODULATORS IN COMBINATION WITH RADIATION TREATMENT

 #37
20170343548
2017-11-30

Method of prognosing and predicting breast cancer recurrence, markers employed therein and kit thereof

 #38
20170335001
2017-11-23

Detection of EphA3 as a Marker of the Presence of a Solid Tumor

 #39
20170266140
2017-09-21

Compositions for modulating cancer stem cells and uses therefor

 #40
20170176418
2017-06-22

DEVICE FOR DETECTION OF DISEASE STATES AND APPLICATIONS OF SAME

 #41
20170081373
2017-03-23

Targeting of chondroitin sulfate glycans

 #42
20170073745
2017-03-16

System and method for capturing and analyzing cells

 #43
20170073392
2017-03-16

CD44 BINDING PEPTIDES

 #44
20170016905
2017-01-19

Targeting of chondroitin sulfate glycans

 #45
20160368992
2016-12-22

A METHOD OF INCREASING GIPCR SIGNALIZATION IN THE CELLS OF A SCOLIOTIC SUBJECT

 #46
20160341728
2016-11-24

BIOMARKERS FOR DETECTION AND DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA

 #47
20160305942
2016-10-20

Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

 #48
20160274121
2016-09-22

Cancer markers and methods of use thereof

 #49
20160187343
2016-06-30

COMPOSITIONS AND METHODS FOR IDENTIFYING A RISK OF CANCER IN A SUBJECT

 #50
20160130352
2016-05-12

RHAMM, A CO-RECEPTOR AND ITS INTERACTIONS WITH OTHER RECEPTORS IN CANCER CELL MOTILITY AND THE IDENTIFICATION OF CANCER PROGNITOR CELL POPULATIONS

 #51
20160024594
2016-01-28

Biomarkers for radiation treatment

 #52
20150301044
2015-10-22

Peptide MHCII tetramers to detect endogenous calnexin specific CD4 T cells

 #53
20150285802
2015-10-08

METHODS FOR TREATING, PREVENTING AND PREDICTING RISK OF DEVELOPING BREAST CANCER

 #54
20150247852
2015-09-03

Markers capable of distinguishing cell pluripotency and uses thereof

 #55
20150219656
2015-08-06

Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

 #56
20150209389
2015-07-30

Methods of generating mesenchymal stem cells which secrete neurotrophic factors

 #57
20150071918
2015-03-12

PEPTIDES FOR THE TREATMENT OF CANCER

 #58
20150037358
2015-02-05

Composition and Methods for Treating Cancer

 #59
20150004099
2015-01-01

Targeting of chondroitin sulfate glycans

 #60
20140329230
2014-11-06

METHODS FOR DETECTING HUMAN PAPILLOMAVIRUS AND PROVIDING PROGNOSIS FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA

 #61
20140212881
2014-07-31

System and method for capturing and analyzing cells

 #62
20140194366
2014-07-10

Ovarian cancer stem cells and methods of isolation and uses thereof

 #63
20130236890
2013-09-12

NOVEL METHOD FOR ANALYZING CIRCULATING TUMOR CELLS OF A PATIENT FOR THE PRESENCE OF METASTASIS-INITIATING CELLS

 #64
20130059903
2013-03-07

Compositions and Methods for Characterizing Breast Cancer

 #65
20120295804
2012-11-22

Compositions and Methods for Diagnosis and Treatment of Breast Cancer

 #66
20120201751
2012-08-09

Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44

 #67
20120165207
2012-06-28

Methods for Monitoring Allograft Rejection

 #68
20120115165
2012-05-10

BIOMARKERS FOR DETECTION AND DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA

 #69
20120107233
2012-05-03

Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44

 #70
20120020880
2012-01-26

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #71
20110318304
2011-12-29

DETECTION OF EPHA3 AS A MARKER OF THE PRESENCE OF A SOLID TUMOR

 #72
20110244501
2011-10-06

CANCER STEM CELLS

 #73
20110229496
2011-09-22

METHOD FOR REGULATING SURVIVAL AND MEMORY OF T HELPER 1 CELLS

 #74
20110151470
2011-06-23

BIOMARKERS FOR ASSESSING RESPONSE TO C-MET TREATMENT

 #75
20110009310
2011-01-13

Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation

 #76
20100323393
2010-12-23

Ordered Assembly of Membrane Proteins During Differentiation of Erythroblasts

 #77
20100267079
2010-10-21

Identification and isolation of transitional cell carcinoma stem cells

 #78
20100143379
2010-06-10

MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF

 #79
20100080784
2010-04-01

METHODS FOR TREATING CACHEXIA AND LYMPHOPENIA

 #80
20100062000
2010-03-11

Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations

 #81
20090325201
2009-12-31

Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma

 #82
20090004103
2009-01-01

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #83
20080274049
2008-11-06

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #84
20080219919
2008-09-11

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #85
20080182278
2008-07-31

Identification and isolation of transitional cell carcinoma stem cells

 #86
20080131429
2008-06-05

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #87
20080124327
2008-05-29

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #88
20080096208
2008-04-24

BIOMARKERS FOR ASSESSING RESPONSE TO C-MET TREATMENT

 #89
20070292441
2007-12-20

CD44E tumor specific antibody

 #90
20070248538
2007-10-25

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #91
20070189964
2007-08-16

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #92
20070179085
2007-08-02

MODULATION OF RHAMM-CAVEOLIN/LIPID RAFT INTERACTIONS TO AFFECT DEVELOPMENT, RESPONSES TO TISSUE INJURY, ANGIOGENESIS, TUMORIGENESIS, METASTASIS AND GROWTH FACTOR/CYTOKINE RESPONSES

 #93
20060216233
2006-09-28

Cytotoxicity mediation of cells evidencing surface expression of CD44

 #94
20050221324
2005-10-06

Genotoxicity analysis

 #95
20050214880
2005-09-29

Salivary soluble CD44: a molecular marker for head and neck cancer

 #96
20050054593
2005-03-10

New drug

 #97
20050031610
2005-02-10

CD44-related fragments, compositions and methods